SE0303268D0 - Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof - Google Patents
Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereofInfo
- Publication number
- SE0303268D0 SE0303268D0 SE0303268A SE0303268A SE0303268D0 SE 0303268 D0 SE0303268 D0 SE 0303268D0 SE 0303268 A SE0303268 A SE 0303268A SE 0303268 A SE0303268 A SE 0303268A SE 0303268 D0 SE0303268 D0 SE 0303268D0
- Authority
- SE
- Sweden
- Prior art keywords
- methods
- angiogenesis
- compositions
- proteins
- relates
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000007435 diagnostic evaluation Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/05—Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0375—Animal model for cardiovascular diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0303268A SE0303268D0 (sv) | 2003-12-05 | 2003-12-05 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
EP04801722A EP1699818A2 (en) | 2003-12-05 | 2004-12-06 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use |
NZ577564A NZ577564A (en) | 2003-12-05 | 2004-12-06 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
PCT/SE2004/001814 WO2005054426A2 (en) | 2003-12-05 | 2004-12-06 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
AU2004295654A AU2004295654A1 (en) | 2003-12-05 | 2004-12-06 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
NZ547877A NZ547877A (en) | 2003-12-05 | 2004-12-06 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
US10/581,761 US20090036362A1 (en) | 2003-12-05 | 2004-12-06 | Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof |
JP2006542541A JP2007512835A (ja) | 2003-12-05 | 2004-12-06 | 新脈管形成に影響を与えるポリペプチド、タンパク質及び組成物、及びそれを使用する方法 |
CA002548208A CA2548208A1 (en) | 2003-12-05 | 2004-12-06 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0303268A SE0303268D0 (sv) | 2003-12-05 | 2003-12-05 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0303268D0 true SE0303268D0 (sv) | 2003-12-05 |
Family
ID=29778161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0303268A SE0303268D0 (sv) | 2003-12-05 | 2003-12-05 | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
Country Status (2)
Country | Link |
---|---|
US (1) | US20090036362A1 (sv) |
SE (1) | SE0303268D0 (sv) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602307A (en) * | 1992-08-12 | 1997-02-11 | Baylor College Of Medicine | Non-human animal having predefined allele of a cellular adhesion gene |
US5489743A (en) * | 1993-01-19 | 1996-02-06 | Amgen Inc. | Transgenic animal models for thrombocytopenia |
US6242179B1 (en) * | 1997-12-17 | 2001-06-05 | Incyte Pharmaceuticals, Inc. | Human phosphatases |
US20030203843A1 (en) * | 2001-04-20 | 2003-10-30 | Pena Carol E. A. | Proteins and nucleic acids encoding same |
US7250495B2 (en) * | 2001-06-20 | 2007-07-31 | Genentech, Inc. | PRO20044 polypeptides |
AU2003295328A1 (en) * | 2002-10-02 | 2004-04-23 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
JP3924306B2 (ja) * | 2005-07-20 | 2007-06-06 | インターナショナル・ビジネス・マシーンズ・コーポレーション | ソフトウェア・パッケージを再構築する方法 |
-
2003
- 2003-12-05 SE SE0303268A patent/SE0303268D0/sv unknown
-
2004
- 2004-12-06 US US10/581,761 patent/US20090036362A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090036362A1 (en) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE269402T1 (de) | Ikk-beta proteine, nukleinsäuren und verfahren | |
DK1641818T3 (da) | Polypeptider der har bindingsaffinitet for HER2 | |
NZ763572A (en) | Trispecific proteins and methods of use | |
CY1115188T1 (el) | Πολυκυκλικες ετεροαρυλ-υποκατεστημενες τριαζολες χρησιμες ως αναστολεις του axl | |
FR16C0021I2 (fr) | Azetidines en tant qu'inhibiteurs de mek et leur utilisation pour le traitement des maladies proliferatives | |
HUP0401591A2 (hu) | Új receptor-nukleinsavak és- polipeptidek | |
CY1115357T1 (el) | Χρηση αναστολεων πεπτιδιου του μονοπατιου μεταγωγης σηματος jnk οι οποιοι διαπερνουν τα κυτταρα για τη θεραπευτικη αγωγη διαφορων νοσηματων | |
WO2004076639A3 (en) | Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus | |
NO20082559L (no) | Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer | |
ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
TW200636076A (en) | Method for measuring resistance or sensitivity to docetaxel | |
ATE421589T1 (de) | Optisches abbildungssystem zur darstellung der genexpression des gesamten körpers und anwendungen | |
DE602005023887D1 (de) | Als b-sekretase (bace)-hemmer nützliche 2-amino-chinazolinderivate | |
DE602004016499D1 (de) | Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung | |
ATE500265T1 (de) | Synthetische mecp2-sequenz für die proteinersatztherapie | |
WO2002088750A3 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
ATE543833T1 (de) | Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen | |
NO20052956D0 (no) | Defensinprotiner | |
RS20050577A (en) | Compositions and methods for treating cancer using igsf9 and liv-1 | |
NO20021146D0 (no) | Polymorfier i de humane CYP3A4- og CYP3A7-genene og deres anvendelse i diagnostiske og terapeutiske anvendelser | |
ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
WO2005054426A3 (en) | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof | |
SE0301987D0 (sv) | New polypeptide | |
SE0303268D0 (sv) | Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof | |
DE602005021159D1 (de) | Bakteriophagen- und prophagen-proteine in der krebsgentherapie |